BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31911987)

  • 1. Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report.
    Hirata Y; Kusunose K; Miki H; Yamada H
    Eur Heart J Case Rep; 2019 Dec; 3(4):1-6. PubMed ID: 31911987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked recovery of cardiac function by chemotherapy and autologous stem cell transplantation of a patient with heart failure with preserved ejection fraction due to primary amyloid light-chain amyloidosis: a case report.
    Tanaka H; Kitao A; Minami H; Hirata KI
    Eur Heart J Case Rep; 2022 Mar; 6(3):ytac016. PubMed ID: 35291337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy.
    Vitarelli A; Lai S; Petrucci MT; Gaudio C; Capotosto L; Mangieri E; Ricci S; Germanò G; De Sio S; Truscelli G; Vozella F; Pergolini MS; Giordano M
    Int J Cardiol; 2018 Nov; 271():371-377. PubMed ID: 30049493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure associated with POEMS syndrome that was adequately distinguished from cardiac amyloidosis: a case report and literature review.
    Hagiwara G; Arahata M; Hosokawa K; Shimojima M; Nakao S
    Ann Transl Med; 2021 Aug; 9(15):1266. PubMed ID: 34532403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
    Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
    J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive heart failure].
    Saito M; Hayashi T; Nojima M; Ikeda H; Tarasawa I; Yasui H; Ishida T; Adachi M; Imai K; Shinomura Y
    Rinsho Ketsueki; 2007 Nov; 48(11):1478-83. PubMed ID: 18080505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.
    Salinaro F; Meier-Ewert HK; Miller EJ; Pandey S; Sanchorawala V; Berk JL; Seldin DC; Ruberg FL
    Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1057-1064. PubMed ID: 27965280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
    Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
    J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing.
    Kyrouac D; Schiffer W; Lennep B; Fergestrom N; Zhang KW; Gorcsan J; Lenihan DJ; Mitchell JD
    ESC Heart Fail; 2022 Feb; 9(1):385-397. PubMed ID: 34877800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative apical sparing obtained with speckle tracking echocardiography is not a sensitive parameter for diagnosing light-chain cardiac amyloidosis.
    Huang PN; Liu YN; Cheng XQ; Liu HY; Zhang J; Li L; Sun J; Gao YP; Lu RR; Gao YP; Deng YB
    Quant Imaging Med Surg; 2024 Mar; 14(3):2357-2369. PubMed ID: 38545064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cardiac diastolic function and prognosis after autologous peripheral blood stem cell transplantation in AL cardiac amyloidosis.
    Yagi S; Akaike M; Ozaki S; Moriya C; Takeuchi K; Hara T; Fujimura M; Sumitomo Y; Iwase T; Ikeda Y; Aihara K; Kimura T; Nishiuchi T; Abe M; Matsumoto T
    Intern Med; 2007; 46(20):1705-10. PubMed ID: 17938525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
    Scully MS; Wessman DE; McKee JM; Francisco GM; Nayak KR; Kobashigawa JA
    Mil Med; 2017 Mar; 182(3):e1858-e1860. PubMed ID: 28290973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al).
    Bellavia D; Abraham RS; Pellikka PA; Dispenzieri A; Burnett JC; Al-Zahrani GB; Green TD; Manske MK; Gertz MA; Miller FA; Abraham TP
    J Am Soc Echocardiogr; 2011 Apr; 24(4):444-54. PubMed ID: 21315556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy.
    Porcari A; Pagura L; Rossi M; Porrazzo M; Dore F; Bussani R; Merlo M; Sinagra G
    Eur Heart J Case Rep; 2022 Apr; 6(4):ytac130. PubMed ID: 35652085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.
    Dimov I; Meuleman N; de Cannière D; Unger P
    Eur Heart J Case Rep; 2021 Aug; 5(8):ytab322. PubMed ID: 34514307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart transplantation and the subsequent treatment of AL amyloidosis].
    Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.